20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Hims Hers Health Inc (HIMS) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in San Francisco, United States with about 2,442 employees. Its market capitalization is roughly $7 billion. In the fiscal year ended 2025-12-31, HIMS reported $2.3B in revenue and $128M in net income.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally.
Interactive charts & full statements → Open the HIMS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.6B | $2.3B | $1.5B | $872M | $527M | $272M | $149M | $83M | $27M |
| Gross Profit | $1.7B | $1.7B | $1.2B | $715M | $409M | $204M | $109M | $45M | $8M |
| Gross Margin % | 64.7% | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% | 29.2% |
| Operating Income (EBIT) | ($93M) | $106M | $62M | ($29M) | ($69M) | ($115M) | ($15M) | ($74M) | ($76M) |
| Operating Margin % | -3.6% | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% | -90.1% | -284.0% |
| Net Income | ($142M) | $128M | $126M | ($24M) | ($66M) | ($108M) | ($18M) | ($72M) | ($75M) |
| Net Margin % | -5.5% | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% | -87.3% | -282.0% |
| EBITDA | ($76M) | $178M | $89M | ($12M) | ($58M) | ($107M) | ($14M) | ($71M) | — |
| Earnings Per Share (EPS) | $-0.63 | $0.50 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 | $-1.12 |
| Shares Outstanding (M) | 232M | 258M | 237M | 209M | 205M | 187M | 35M | 35M | 67M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $753M | $608M | $618M | $599M | $545M | $586M | $481M | $402M |
| Gross Profit | $481M | $300M | $444M | $442M | $416M | $431M | $370M | $318M |
| Gross Margin % | 63.8% | 49.4% | 71.9% | 73.8% | 76.4% | 73.5% | 76.8% | 79.2% |
| Operating Income (EBIT) | ($97M) | ($16M) | $9M | $12M | $27M | $58M | $19M | $22M |
| Operating Margin % | -12.9% | -2.7% | 1.5% | 2.0% | 4.9% | 9.9% | 3.9% | 5.6% |
| Net Income | ($86M) | ($92M) | $21M | $16M | $43M | $49M | $26M | $76M |
| Net Margin % | -11.5% | -15.2% | 3.3% | 2.6% | 7.8% | 8.4% | 5.4% | 18.8% |
| EBITDA | ($63M) | ($80M) | $36M | $30M | $43M | $69M | $28M | $28M |
| Earnings Per Share (EPS) | $-0.37 | $-0.40 | $0.08 | $0.06 | $0.17 | $0.20 | $0.11 | $0.32 |
| Shares Outstanding (M) | 232M | 228M | 248M | 249M | 257M | 247M | 241M | 235M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $267M | $300M | $251M | $73M | ($27M) | ($34M) | ($2M) | ($75M) | ($57M) |
| Capital Expenditures (CapEx) | $177M | $226M | $53M | $26M | $7M | $5M | $4M | $2M | $0M |
| Free Cash Flow (FCF) | $90M | $74M | $198M | $47M | ($34M) | ($39M) | ($7M) | ($77M) | ($57M) |
| FCF Margin % | 3.5% | 3.1% | 13.4% | 5.4% | -6.4% | -14.5% | -4.5% | -92.8% | -214.9% |
| Dividends Paid | — | — | — | — | — | — | $2M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($36M) | $89M | $65M | $149M | ($19M) | $109M | $86M | $85M |
| Capital Expenditures (CapEx) | $19M | $36M | $64M | $57M | $50M | $59M | $27M | $6M |
| Free Cash Flow (FCF) | ($55M) | $53M | $1M | $91M | ($69M) | $50M | $60M | $79M |
| FCF Margin % | -7.3% | 8.7% | 0.1% | 15.3% | -12.7% | 8.5% | 12.4% | 19.8% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.6B | $2.2B | $708M | $441M | $366M | $421M | $119M | $72M | $48M |
| Cash & Cash Equivalents | $610M | $229M | $221M | $97M | $47M | $72M | $27M | $23M | $42M |
| Total Liabilities | $3.3B | $1.6B | $231M | $97M | $55M | $86M | $266M | $207M | $25M |
| Total Debt (Short + Long-Term) | $12M | $977M | $2M | $1M | $2M | $1M | $4M | $2M | $8M |
| Total Shareholders' Equity | $324M | $541M | $477M | $344M | $312M | $335M | ($147M) | ($135M) | $23M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HIMS viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms